Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Fruquintinib in Patients With Metastatic Colorectal Cancer — Stella

Home/Metastatic Colorectal Cancer (mCRC)/Fruquintinib in Patients With Metastatic Colorectal Cancer

View on ClinicalTrials.gov

Recruiting

Back to Metastatic Colorectal Cancer (mCRC) trials

Fruquintinib in Patients With Metastatic Colorectal Cancer

Trial locations(1 site)

Germany

Onkologische Schwerpunktpraxis, Hanover, Lower Saxony

Key details

Sponsor

iOMEDICO AG

Collaborators

Takeda GmbH

Enrollment target

~150 participants

Started

February 2025

Primary completion

December 2027

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.